1. Home
  2. GMED vs OXLCN Comparison

GMED vs OXLCN Comparison

Compare GMED & OXLCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • OXLCN
  • Stock Information
  • Founded
  • GMED 2003
  • OXLCN N/A
  • Country
  • GMED United States
  • OXLCN United States
  • Employees
  • GMED N/A
  • OXLCN N/A
  • Industry
  • GMED Medical/Dental Instruments
  • OXLCN Investment Managers
  • Sector
  • GMED Health Care
  • OXLCN Finance
  • Exchange
  • GMED Nasdaq
  • OXLCN Nasdaq
  • Market Cap
  • GMED 9.6B
  • OXLCN N/A
  • IPO Year
  • GMED 2012
  • OXLCN N/A
  • Fundamental
  • Price
  • GMED $55.81
  • OXLCN $23.91
  • Analyst Decision
  • GMED Buy
  • OXLCN
  • Analyst Count
  • GMED 13
  • OXLCN 0
  • Target Price
  • GMED $95.09
  • OXLCN N/A
  • AVG Volume (30 Days)
  • GMED 1.4M
  • OXLCN N/A
  • Earning Date
  • GMED 05-08-2025
  • OXLCN N/A
  • Dividend Yield
  • GMED N/A
  • OXLCN N/A
  • EPS Growth
  • GMED 145.70
  • OXLCN N/A
  • EPS
  • GMED 1.34
  • OXLCN N/A
  • Revenue
  • GMED $2,510,810,000.00
  • OXLCN N/A
  • Revenue This Year
  • GMED $9.12
  • OXLCN N/A
  • Revenue Next Year
  • GMED $6.91
  • OXLCN N/A
  • P/E Ratio
  • GMED $41.67
  • OXLCN N/A
  • Revenue Growth
  • GMED 32.26
  • OXLCN N/A
  • 52 Week Low
  • GMED $49.33
  • OXLCN N/A
  • 52 Week High
  • GMED $94.93
  • OXLCN N/A
  • Technical
  • Relative Strength Index (RSI)
  • GMED 23.18
  • OXLCN 55.92
  • Support Level
  • GMED $69.72
  • OXLCN $23.70
  • Resistance Level
  • GMED $73.05
  • OXLCN $23.82
  • Average True Range (ATR)
  • GMED 1.98
  • OXLCN 0.05
  • MACD
  • GMED -0.81
  • OXLCN 0.03
  • Stochastic Oscillator
  • GMED 6.73
  • OXLCN 100.00

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About OXLCN Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Share on Social Networks: